ADD1

ADD1 Full Name

adducin 1 (alpha)

ADD1 Introduction

ADD1 encodes α-adducin, the founding member of the adducin family of cytoskeletal proteins, which also includes β-adducin (ADD2) and γ-adducin (ADD3). The gene is located on chromosome 4p16.3 and encodes a protein of approximately 737 amino acids. Structurally, α-adducin is organized into three functional domains: an N-terminal globular head domain responsible for actin binding; a neck domain that connects to the tail; and a C-terminal tail domain that mediates heterodimer formation with β- or γ-adducin and harbors a conserved MARCKS-related domain (MRD) containing key phosphorylation sites for protein kinase C (PKC) and Rho kinase. In cells, adducin heterodimers — predominantly α/β in most tissues and α/γ in the brain — associate with the barbed ends of actin filaments and stabilize spectrin–actin junctions in the membrane skeleton. This positioning places adducin at a critical nexus between the lipid bilayer and the underlying cytoskeletal network, influencing membrane stability, cell shape, and the subcellular localization of transmembrane proteins, including ion transporters and pumps.

Figure 1. The structural proteins in the spectrin-based membrane skeleton at the cytoplasmic surface of plasma membrane. (Source: Kiang KM, et al. 2018)

A particularly well-characterized function of ADD1 involves the regulation of renal sodium handling. α-Adducin stimulates the activity of the Na⁺/K⁺-ATPase (sodium-potassium pump) on the basolateral membrane of renal tubular epithelial cells, thereby increasing sodium reabsorption. Phosphorylation of the MRD by PKC inhibits adducin–actin binding and reduces pump activity, providing a dynamic regulatory switch. The precise modulation of renal Na⁺ transport by adducin links ADD1 directly to blood pressure homeostasis: enhanced α-adducin activity promotes sodium and water retention, elevating circulating volume and blood pressure. This mechanism is further modulated by the cytoskeletal context of the spectrin–actin lattice, which positions Na⁺/K⁺-ATPase molecules in proximity to their regulatory partners.

The most extensively studied human variant in ADD1 is the Gly460Trp polymorphism, located in exon 10, in which a glycine-to-tryptophan substitution at position 460 alters the structural stability of the adducin tail domain and augments Na⁺/K⁺-ATPase stimulatory activity. Epidemiological studies have consistently linked the 460Trp (T) allele with elevated risk of essential hypertension, particularly in salt-sensitive individuals and in Asian populations. A large meta-analysis confirmed a statistically significant association between the T allele and hypertension susceptibility, with effects appearing more pronounced in females and in populations with high dietary sodium intake. A haplotype analysis in Chinese Han populations further identified a risk haplotype conferring an approximately 1.36-fold increased risk for essential hypertension. Beyond hypertension, ADD1 polymorphisms have been associated with salt-sensitive renal dysfunction, subclinical stroke risk, and cardiovascular events in hypertensive patients. ADD1 variants have also been implicated in response to antihypertensive therapy — particularly thiazide diuretics — highlighting their clinical relevance for pharmacogenomics-guided treatment strategies in the management of cardiovascular disease.

Alternate Names for ADD1

ADD1; adducin 1 (alpha); AI256389; alpha-adducin; erythrocyte adducin subunit alpha;

• 1. Kiang KM, et al. A Review on Adducin from Functional to Pathological Mechanisms: Future Direction in Cancer. Biomed Res Int. 2018 May 16;2018:3465929.
  2. Zhang Y, et al. ADD1 Single Nucleotide Polymorphisms Are Associated With Essential Hypertension Among Han and Mongolian Population in Inner Mongolia Area. Front Genet. 2022 Aug 12;13:931803.